News Digest #211 – SynBioBeta Q1 Breaks $650m, Trump Appoints Elizabeth Holmes to FDA.

 

Hi all,

The synthetic biology industry raised over $650 million in Q1, more than double Q1 2017, setting the pace for another record-breaking year. The infographic below shows the big movers, and we’ll go deeper into all the companies in next week’s digest. You can hear Wild Earth, Opentrons, Prokarium, Twist Bioscience and many more speaking at SynBioBeta in October — register by Friday April 6th before the early bird discount ends.



A new report from Cambridge Consultants (one of SynBioBeta’s sponsors) says that for synthetic biology to become a commercially-focused technology in the next five years, it will need to achieve predictability, a competitive supply-chain, and accessibility.

Regards,
John
Trump taps Elizabeth Holmes to lead FDA
SGI-DNA launches automated gene libraries for drug discovery
Can bacteria in clothing really make an athlete faster?

Who’s Hiring?

Research Fellow in Open Synthetic Biology: CRI, Paris


Synthetic biologist/Protein engineer: XENO Cell Innovations, Pilsen, Czech Republic


Product Manager, Cells: Synthego, California


Senior QA Specialist: Synthego, California


To feature your job here, please get in touch

 

All the News

DNA testing, biocarbon and custom microbes: how these startups are improving soil health (Forbes)


In a big win for the biotech industry, the USDA says it won’t regulate gene-edited plants (MIT Technology Review)


Novel synthetic biology technique could lead to breakthroughs in disease treatment (Northeastern University)


CRISPR’d food, coming soon to a supermarket near you (Wired)


Neil Goldsmith joins Unibio’s board of directors (Press Release)


Designing new proteins could become as significant as tweaking DNA (Bloomberg)


Breakout Labs raises its maximum available grant for deep-technology startups to $500,000


CRISPR may not cause hundreds of rogue mutations after all (MIT Technology Review)


3 biotech megatrends that will shape 2018 & beyond (SOSV)


The role of synthetic biology as a basic research facilitator (PLOS Synbio)


Why Devang Mehta is quitting GMO research (Massive Science)


Copyright © %%current_year_YYYY%%, All rights reserved.

SynBioBeta
1547 Palos Verdes Mall, #411
Walnut Creek, CA 94597

About Us | Update Preferences | Unsubscribe | View email in your browser

Stay updated on the latest news in synthetic biology

Join our weekly newsletter

Sign up

Add comment

Job opportunities

More